CEO Departure at Lykos Therapeutics Following FDA Rejection of Ecstasy-based Therapy
In a recent development, Lykos Therapeutics' CEO Amy Emerson has stepped down from her role following the rejection of...
PTSD
FDA Rejection Hits Psychedelic Drug Stocks Amid PTSD Treatment Hopes
In a blow to companies developing treatments for mental illnesses using mind-altering substances like psilocybin and LSD, the FDA...
Concerns Arise Over MDMA Trials for PTSD Treatment
In a pivotal moment for mental health treatment, the FDA is set to decide whether to approve MDMA, an...
Should I Sell My Condo in California?
**Lead:** A woman in Southern California faces a tough decision - sell her condo or rent it out? With...
The Rise of Breathwork: Paying for the Art of Breathing
Breathwork is becoming a booming industry as people seek to improve their well-being and manage stress and anxiety. Experts...
Boulder Crest Foundation: Helping Veterans and First Responders with Mental Health Care
Ken Falke, a 21-year Navy veteran, and his wife, Julia, have dedicated their lives to helping wounded service members...
Blake Mycoskie: Tackling the US Mental Health Crisis Through Philanthropy and Psychedelics
Blake Mycoskie, the founder of Toms Shoes, is now dedicating one-quarter of his net worth, or $100 million, to...
Blake Mycoskie of Toms Shoes: Philanthropy and Mental Health
Blake Mycoskie, the founder of Toms Shoes, is dedicating one-quarter of his net worth, which amounts to $100 million,...
Lykos Therapeutics Raises $100M in Funding for Psychedelic-Assisted Therapy
Lykos Therapeutics, formerly known as MAPS Public Benefit Corp., has raised $100 million in a Series A funding round...
Ibogaine: A Promising Treatment for Veterans with PTSD
A recent study published in the journal Nature Medicine reveals that 30 special operations forces veterans experienced significant relief...